Bbr Partners, LLC Lyell Immunopharma, Inc. Transaction History
Bbr Partners, LLC
- $1.41 Billion
- Q4 2024
A detailed history of Bbr Partners, LLC transactions in Lyell Immunopharma, Inc. stock. As of the latest transaction made, Bbr Partners, LLC holds 164,041 shares of LYEL stock, worth $109,907. This represents 0.01% of its overall portfolio holdings.
Number of Shares
164,041
Previous 164,041
-0.0%
Holding current value
$109,907
Previous $226,000
53.98%
% of portfolio
0.01%
Previous 0.02%
Shares
1 transactions
Others Institutions Holding LYEL
# of Institutions
108Shares Held
171MCall Options Held
7.7KPut Options Held
15.3K-
Mwg Management Ltd. Washington, DC20.2MShares$13.5 Million17.35% of portfolio
-
Apoletto LTD Washington, DC15.1MShares$10.1 Million42.56% of portfolio
-
Orland Properties LTD Washington, DC15.1MShares$10.1 Million14.08% of portfolio
-
Black Rock Inc. New York, NY13.5MShares$9.04 Million0.0% of portfolio
-
Decheng Capital LLC Menlo Park, CA11.9MShares$7.98 Million1.63% of portfolio
About Lyell Immunopharma, Inc.
- Ticker LYEL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 247,824,992
- Market Cap $166M
- Description
- Lyell Immunopharma, Inc., a T cell reprogramming company, engages in developing T cell therapies for patients with solid tumors. The company develops therapies using technology platforms, such as Gen-R, an ex vivo genetic reprogramming technology to overcome T cell exhaustion; and Epi-R, an ex vivo epigenetic reprogramming technology to generate...